BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7791149)

  • 1. Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases.
    Anaya JM; Espinoza LR
    J Rheumatol; 1995 Apr; 22(4):595-9. PubMed ID: 7791149
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline.
    Coimbra R; Melbostad H; Hoyt DB
    J Trauma; 2004 Feb; 56(2):442-9. PubMed ID: 14960994
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of inflammatory rheumatic diseases].
    Keitel W
    Z Arztl Fortbild (Jena); 1987; 81(9):439-41. PubMed ID: 3498268
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentoxifylline: a drug with wide spectrum applications in dermatology.
    Zargari O
    Dermatol Online J; 2008 Nov; 14(11):2. PubMed ID: 19094840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative.
    el-Mofty M; el-Darouti M; Rasheed H; Bassiouny DA; Abdel-Halim M; Zaki NS; el-Hanafy G; el-Hadidi H; Azzam O; el-Ramly A; Fawzy M
    J Dermatolog Treat; 2011 Feb; 22(1):31-7. PubMed ID: 20073999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy of rheumatic diseases].
    Gaja A; Vykydal M
    Acta Univ Palacki Olomuc Fac Med; 1985; 108():295-300. PubMed ID: 3161288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study with isonixine].
    Asensi E; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1977; 20(2):159-67. PubMed ID: 327518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
    Mariani L; Baratelli M
    Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ground rules in pharmacotherapy of rheumatic diseases].
    Wessel G; Reinicke C
    Z Gesamte Inn Med; 1980 Nov; 35(22):suppl 157-60. PubMed ID: 6970456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ketoprofen--a first class nonsteroidal anti-arrhythmia agent].
    Z Orthop Ihre Grenzgeb; 1997; 135(1 Suppl):1-8. PubMed ID: 9209544
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatment in rheumatism.
    Huskisson E
    Physiotherapy; 1977 Dec; 63(12):398-9. PubMed ID: 305052
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F; Polak T; Günther A; Kubuschok B; Janovskaja J; Bitsch A; Poser S; Rieckmann P
    Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple organ failure].
    Grinëv MV; Golubeva AV
    Vestn Khir Im I I Grek; 2001; 160(3):110-4. PubMed ID: 11517779
    [No Abstract]   [Full Text] [Related]  

  • 16. [New drug treatments for rheumatoid arthritis].
    Nordström DC; Konttinen YT
    Duodecim; 2000; 116(11):1221-5. PubMed ID: 11989008
    [No Abstract]   [Full Text] [Related]  

  • 17. Leflunomide.
    Mehta V; Kisalay S; Balachandran C
    Indian J Dermatol Venereol Leprol; 2009; 75(4):422-4. PubMed ID: 19584481
    [No Abstract]   [Full Text] [Related]  

  • 18. Supportive pharmacotherapy for patients with acute respiratory distress syndrome.
    Krafft P; Fridrich P; Hammerle AF; Steltzer H
    Acta Anaesthesiol Scand Suppl; 1996; 109():65-9. PubMed ID: 8901950
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 20. [Free oxygen radicals. Their role in the physiopathology of rheumatic diseases and therapeutic implications].
    Allegrezza Giulietti A; Muti S; Piergiacomi G
    Clin Ter; 1987 Sep; 122(6):445-57. PubMed ID: 2972458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.